ArticleOncotarget2017
DUSP4 is associated with increased resistance against anti-HER2 therapy in breast cancer.
Otília Menyhart et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
21 papers cite it
this papercites it
ArticleOncotarget2017
Otília Menyhart et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.